Andrew Wang

Journal Article JACC Cardiovasc Imaging · March 2025 BACKGROUND: In severely symptomatic patients with obstructive hypertrophic cardiomyopathy (HCM), the VALOR-HCM (A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Who Are Eligible for Septal Reduction Therapy) ... Full text Link to item Cite

Axillary Artery Versus Femoral or Central Arterial Cannulation in Minithoracotomy Mitral Surgery: Is There a Difference in Early Outcomes?

Journal Article Innovations (Phila) · February 14, 2025 OBJECTIVE: Axillary artery cannulation techniques continue to improve and find application throughout cardiac surgery. Yet, early outcomes are poorly documented versus femoral or central arterial cannulation in right minithoracotomy mitral surgery. METHODS ... Full text Link to item Cite

Prognostic Implication of Left Ventricular Global Longitudinal Strain in Patients With Hypertrophic Cardiomyopathy and Coexisting Hypertension.

Journal Article Korean Circ J · February 4, 2025 BACKGROUND AND OBJECTIVES: The prognostic implication of coexisting hypertension in patients with hypertrophic cardiomyopathy (HCM) is poorly defined. This study aimed to evaluate the association between left ventricular global longitudinal strain (LV-GLS) ... Full text Link to item Cite

View All Publications

Recent Grants

Percutaneous or Surgical Mitral Valve Repair in Patients with Primary Mitral Regurgitation whose mitral valve has been determined to be suitable for correction by MV repair surgery

Clinical TrialPrincipal Investigator · Awarded by Evalve, Inc · 2021 - 2033

Discover- HCM

Clinical TrialPrincipal Investigator · Awarded by Bristol-Myers Squibb Company · 2022 - 2030

Machine Learning Guided Precision Genetic Testing for Identification of Monogenic Cardiovascular Disorders

ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2028

View All Grants

Education, Training & Certifications

Duke University · 1990 M.D.